Is immobilization associated with an abnormal lipoprotein profile? Observations from a diverse cohort

Spinal Cord

Volumn 37, Issue 7, 1999, Pages 485-493

  Bauman, W A ^a,b,c,d   Adkins, R H ^d   Spungen, A M ^a,b,d   Herbert, R ^a   Schechter, C ^a   Smith, D ^b   Kemp, B J ^d,e   Gambino, R ^f   Maloney, P ^f   Waters, R L ^d,e  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^e LAC USC MEDICAL CENTER   (United States)

^f QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

Author keywords

Coronary heart disease; Ethnicity; Gender; High density lipoprotein cholesterol; Spinal cord injury

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; DIET RESTRICTION; ETHNIC GROUP; FEMALE; GENDER; HUMAN; HUMAN CELL; IMMOBILIZATION; LABORATORY TEST; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SPINAL CORD INJURY; STATISTICAL ANALYSIS;

EID: 0032782969     PISSN: 13624393     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.sc.3100862     Document Type: Article

References (49)

1. 1 Whiteneck G. Learning from Recent Empirical Investigations. In: Menter R, Whiteneck G (eds). Aging with Spinal Cord Injury. Demos Publications: New York, NY, 1992, pp 23-37.
2. 2 Yekutiel M et al. The prevalence of hypertension, ischemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 1989; 27: 58-62.
3. 3 Geisler WO, Joussy AT, Wynne-Jones M, Breithaupt D. Survival in traumatic spinal cord injury. Paraplegia 1983; 21: 364-373.
4. 4 Samsa P, Patrick C, Feussner JR. Long term survival of veterans with traumatic spinal cord injury. Arch Neurol 1993; 50: 909-914.
5. 5 Castelli WP et al. HDL-cholesterol and other lipids in coronary heart disease: the cooperative lipoprotein phenotyping study. Circulation 1977; 55: 767-777.
6. 6 Goldbour U, Medalie JH. High density lipoprotein cholesterol and incidence of coronary heart disease: The Israeli ischemic heart disease study. Am J Epidemiol 1979; 109: 296-308.
7. 7 Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am J Med 1984; 76 (2A): 4-12.
8. 8 Castelli WP, Leaf A. Identification and assessment of cardiac risk an overview. Cardiol Clin. 1985; 3: 171-178.
9. 9 Gordon T, Castelli WP. High density lipoprotein as a protective factor against CHD: The Framingham Study. Am J Med 1977; 62: 707-709.
10. 10 Bauman WA et al. Depressed serum high density lipoprotein cholesterol levels in veterans with spinal cord injury. Paraplegia 1992; 30: 697-703.
11. 11 LaPorte RE et al. HDL-cholesterol across a spectrum of physical activity from quadriplegia to marathon running. Lancet 1983; 1: 1212-1213.
12. 12 Brenes G et al. High density lipoprotein cholesterol concentrations in physically active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 1986; 67: 445-450.
13. 13 Dearwater SR et al. Activity in the spinal cord-injured patient: An epidemiologic analysis of metabolic parameters. Med Sci Sports Exerc 1986; 18: 541-544.
14. 14 Hooker SP, Wells CL. Effects of low-and moderate-intensity training in spinal cord-injured persons. Med Sci Sports Exerc 1989; 21: 18-22.
15. 15 Bauman WA et al. The effect of residual neurological deficit on serum lipoprotein profiles in persons with chronic spinal cord injury. Spinal Cord 1998; 36: 13-17.
16. 16 Bauman WA et al. Ethnicity effect on the serum lipid profile in persons with spinal cord injury. Arch Phy Med Rehabil 1998; 79: 176-180.
17. 17 Herbert R et al. Occupational Coronary Heart Disease among Bridge and Tunnel Officers. (in press).
18. 18 Friedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
19. 19 Summary of the second report of the national Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel II). American Medical Association. JAMA 1993; 269: 3015-3023.
20. 20 Kannel WB, Wilson PWF. Efficacy of lipid profiles in prediction of coronary disease. Amer Heart J 1992; 124: 768-774.
21. 21 Stampfer MJ et al. A prospective study of cholesterol, apolipoprotein values and the risk of myocardial infarction. N Engl J Med 1991; 325: 373-381.
22. 22 National Institutes of Health Consensus Development Panel Conference Statement: Health implications of obesity. Ann Intern Med 1976; 60: 80-88.
23. 23 Cohen J. In: Statistical Power Analysis for the Behavioral Sciences. 2nd Edn. Lawrence Erlbaum Associates: Hillsdale, New Jersey 1988, pp 211-214.
24. 24 Grundy SM et al. The place of HDL in cholesterol management. A perspective from the national cholesterol education program. Arch Intern Med 1989; 149: 505-510.
25. 25 Criqui MH et al. Cigarette smoking and plasma high-density lipoprotein cholesterol. Ther lipid research clinics program prevalence study. Circulation 1980; 62(suppl IV): 70-76.
26. 26 Facchini FS et al. Insulin resistance and cigarette smoking. Lancet 1992; 339: 1128-1130.
27. 27 Spungen AM, Bauman WA, Almenoff PL, Lesser M. Prevalence of cigarette smoking in a group of male veterans with chronic spinal cord injury. Military Med 1992; 160: 308-311.
28. 28 Centers for Disease Control: Cigarette smoking among adults United States. MMWR 1992; 41: 354-355.
29. 29 Spungen AM, Bauman WA, Adkins RH, Waters RL. Smoking prevalence in a diverse California-based out-patient population with spinal cord injury. J Spinal Cord Med 1998; 21: 176.
30. 30 Haskell WL et al. The effect of cessation and resumption of moderate alcohol intake on serum high-density-lipoprotein subfractions. A controlled study. N Engl J Med 1984; 310: 805-810.
31. 31 Bertiere MC, Betoulle D, Apfelbaum M, Girard-Globa A. Time-course, magnitude and nature of the changes induced in HDL by moderate alcohol intake in young non-drinking males. Atherosclerosis 1986; 61: 7-14.
32. 32 Rosman AS. Utility and evaluation of biochemical markers of alcohol consumption. J Substanee Abuse 1992; 4: 277-297.
33. 33 Rosman AS, Leiber CS. Biological Markers of Alcoholism. In: Leiber CS (ed). Medical and Nutritional Complications of Alcoholism. Plenum Press, New York, NY 1992, pp 534-536.
34. 34 Salaspuro M. Conventional and coming laboratory markers of alcoholism and heavy drinking. Alcoh Clin Exp Res 1986; 10: 5S-12S.
35. 35 Zlototow SP, Levy E, Bauman WA. The serum lipoprotein profile in veterans with paraplegia: the relationship to nutritional factors and body mass index. J Amer Paraplegia Soc 1992; 15: 158-162.
36. 36 Tikkanen MJ. Estrogens, progestins and lipid metabolism. Maturitas 1996; S51-S55.
37. 37 Rubins HB et al. Distribution of lipids in 8,500 men with coronary artery disease. Department of Veterans Affairs HDL Intervention Trial Study Group. Am J Cardiol 1995; 75: 1196-1201.
38. 38 Sprafka JM et al. Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology 1992; 3: 156-163.
39. 39 Anderson RA et al. Genetic markers associated with high density lipoprotein cholesterol levels in a biracial population study. Genet Epidemiol 1992; 9: 109-121.
40. 40 Srinivasan SR, Powers CR, Webber LS, Berenson GS. Serum lipid and lipoprotein profiles of military personnel and their families: Fort Polk Heart Smart Program. Mil Med 1993; 158: 323-326.
41. 41 The Lipid Research Clinics Coronary Primary Prevention Trial Results, II: The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 1984; 251: 365-374.
42. 42 Randomized trial of cholesterol lowering in 444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S): Lancet 1994: 344: 1383-1389.
43. 43 Shepherd J et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-1307.
44. 44 Frisk MH et al. Helsinki Heart Study; Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987; 317: 1237-1245.
45. 45 Yalow RS, Rose HG, Bauman WA. Hyperinsulinemia. Am J Med 1988; 85: 22-30.
46. 46 Reaven GM, Greenfield MS. Diabetic hypertriglyceridemia: Evidence for three clinical syndromes. Diabetes 1981; 30: 66-75.
47. 47 Golay A et al. High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: Meusurement of fHDL turnover using tritiated HDL. J Clin Endocrinol Metab 1987; 65: 512-518.
48. 48 Reaven GM. Syndrome X. Clin Diabetes 1994; March-April 32 36.
49. 49 DeFronzo RA, Ferrannini E. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.